Clinical and Translational Medicine (Feb 2021)
Schisandrin B for the treatment of male infertility
- Di‐Xin Zou,
- Xue‐Dan Meng,
- Ying Xie,
- Rui Liu,
- Jia‐Lun Duan,
- Chun‐Jie Bao,
- Yi‐Xuan Liu,
- Ya‐Fei Du,
- Jia‐Rui Xu,
- Qian Luo,
- Chong‐jun Zhao,
- Zhan Zhang,
- Shuang Ma,
- Wei‐Peng Yang,
- Rui‐Chao Lin,
- Wan‐Liang Lu
Affiliations
- Di‐Xin Zou
- Institute of Chinese Materia Medica China Academy of Chinese Medical Science Beijing 100700 China
- Xue‐Dan Meng
- Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 China
- Ying Xie
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Rui Liu
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Jia‐Lun Duan
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Chun‐Jie Bao
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Yi‐Xuan Liu
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Ya‐Fei Du
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Jia‐Rui Xu
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Qian Luo
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Chong‐jun Zhao
- Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 China
- Zhan Zhang
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Shuang Ma
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- Wei‐Peng Yang
- Institute of Chinese Materia Medica China Academy of Chinese Medical Science Beijing 100700 China
- Rui‐Chao Lin
- Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica Beijing University of Chinese Medicine Beijing 100102 China
- Wan‐Liang Lu
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Maolecular Pharmaceutics and New Drug System, and Scool of Pharmaceutical Sciences Peking University Beijing 100191 China
- DOI
- https://doi.org/10.1002/ctm2.333
- Journal volume & issue
-
Vol. 11,
no. 2
pp. n/a – n/a
Abstract
No abstracts available.
